
Acquisition Bolsters Aspire’s Strategic Portfolio
Petersfield, Hampshire, 08 May 2025, Aspire Pharma Limited, a rapidly growing UK-based specialty niche generics business, announces the bolstering of its product portfolio through the purchase of UK distribution rights to a number of products…
